Limited Ozempic supplies to commence distribution in Australia
- TGA has published a Joint statement on supply allocations of intravenous tocilizumab (Actemra) during serious shortage.
- The TGA is aware of several scams targeting consumers seeking semaglutide (Ozempic). Consumers are strongly advised not to use products unless they have come from a trusted source.
- Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies